Author Archive

Unlocking the Mystery of Angel Investment

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. In the “Mystery of Capital,” Peruvian economist Hernando de Soto famously writes about the need to convert assets into capital for creation of social and economic value in […]


More on The Success Matrix

Gerry Langeler, author of The Success Matrix and Managing Director with OVP Venture Partners recently spoke at a breakfast event and was kind enough to record the video. Gerry’s thoughts on ‘Why scientists fail as entrepreneurs‘ was previously featured on the BiotechBlog, and his video is posted below. For more, you can also visit Gerry’s website at www.thesuccessmatrix.com.  


Key Elements of Succession Planning In Bioscience

This is a guest post from Steve McLaughlin, Managing Partner and Founder of US BioSearch. Do you have a response to Steve’s post? Respond in the comments section below. Effective succession plans involve a combination of many choices and decisions that are distinctive to each, specific company. Bioscience companies also present their own, unique challenges, as […]


Building Biotechnology in Poland

I will be presenting at Bioinnovation 2014 in Gdansk, Poland on October 20-21st. My talk will cover entrepreneurship and business development guidance from my textbook, Building Biotechnology and global competitiveness considerations from my global biotechnology ranking for Scientific American Worldview. I look forward to meeting European and Polish biotechnology practitioners, and learning more about biotechnology […]


Maintaining your independence in biotechnology

Mergers and acquisitions are regular events for biotechnology companies. I have often been asked if being acquired is a goal for biotechnology companies, and if it is seen as a ‘good’ or a ‘bad’ thing. The outlook on merging with another company, or being acquired, is really just a matter of timing. As I describe […]


Adventures in Data Wrangling

I will be giving a talk on September 10th at George Washington University on two recent data analytics projects: Firstly, I will present Scientific American Worldview, a global biotechnology ranking I developed six years ago and have managed since. The primary challenges in developing Worldview have been ensuring that the product is accessible to a […]


Biotechnology in Countries Starting with “I” – Part 6: Iceland

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. Once again we have reached the dog-days of summer in Washington DC, when it is nice to day-dream about biotechnology in cooler climates. There may be no better destination […]


Leadership Skills in the Biotech Start-Up

This is a guest post from Isabela Oliva. Do you have a response to Isabela’s post? Respond in the comments section below. How to survive the expected and unexpected challenges of the start-up lifecycle in the biotechnology business A major difference between biotechnology and information technology ventures is the time it takes to bring a product […]


Genomics: A promising investment opportunity

This is a guest post from Zhen-Xia Chen. Do you have a response to Zhen-Xia’s post? Respond in the comments section below. The name of “genomics” originated with the birth of a new journal “Genomics” in 1987.   The journal adopted the term genomics for “the newly developing discipline of mapping/sequencing (including the analysis of the […]